false 0001308547 0001308547 2025-01-29 2025-01-29

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

January 29, 2025

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Section 2 - Financial Information

 

ITEM 2.02

Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On January 29, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended December 27, 2024. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Section 8 – Other Events

 

ITEM 8.01

Other Events

Declaration of Dividend

On January 29, 2025, the Company announced a cash dividend of $0.33 per share of Class A and Class B Common Stock, payable on February 19, 2025 to stockholders of record as of the close of business on February 11, 2025.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

Section 9 - Financial Statements and Exhibits

 

ITEM 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description

99.1    Press Release of Dolby Laboratories, Inc. dated January 29, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:  

/s/ Robert Park

  Robert Park
  Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: January 29, 2025

Exhibit 99.1

Dolby Laboratories Reports First Quarter 2025 Financial Results

SAN FRANCISCO, January 29, 2025 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the first quarter of fiscal 2025.

“We are off to a strong start for FY25,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto.”

First Quarter Fiscal 2025 Financial Highlights

 

   

Total revenue was $357 million, compared to $316 million for the first quarter of fiscal 2024.

 

   

GAAP net income was $68 million or $0.70 per diluted share, compared to GAAP net income of $67 million or $0.69 per diluted share for the first quarter of fiscal 2024. On a non-GAAP basis, first quarter net income was $111 million or $1.14 per diluted share, compared to $99 million or $1.01 per diluted share for the first quarter of fiscal 2024.

 

   

Dolby repurchased approximately 186,000 shares of its common stock for approximately $15 million, and ended the quarter with approximately $387 million of stock repurchase authorization available going forward.

A complete listing of Dolby’s non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

 

   

At CES, our partners announced a wide range of new products incorporating Dolby technologies, including:

 

   

Soundbar announcements from Harmon Kardon, Samsung, and Amazon all support Dolby technology.

 

   

TV launches from partners including Hisense, TCL, Panasonic, Sharp, and RCA support Dolby Atmos and Dolby Vision.

 

   

In Auto, Samsung Display is working with Dolby to pre tune its cutting edge OLED displays for autos to deliver Dolby Vision to more cars, Texas Instruments announced that it would support Dolby Atmos in its new family of chips for automakers, and Pioneer showcased how Dolby Atmos could be used in an aftermarket solution using a 4-channel speaker system.

 

   

In PCs, ASUS, Dell, Lenovo, and Samsung announced a variety of new PCs, laptops, and monitors that support Dolby Vision and/or Dolby Atmos.

 

   

Social Media app Xiaohongshu, which goes by the name RedNote in the U.S., now supports Dolby Vision.

 

   

Amazon announced that the Fire TV Omni Mini-LED will support Dolby Atmos and Dolby Vision.

 

   

All eight of the 2025 Grammy nominees for best new artist are available in Dolby Atmos, and seven out of eight Grammy nominees for Record of the Year and Album of the Year are available in Dolby Atmos.

 

   

In 2024, over 80% of domestic box office and almost 70% of global box office came from Hollywood and local titles released in Dolby Atmos and Dolby Vision.

Dividend

Today, Dolby announced a cash dividend of $0.33 per share of Class A and Class B common stock, payable on February 19, 2025, to stockholders of record as of the close of business on February 11, 2025.


Financial Outlook

Dolby’s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby’s future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Quarterly Report on Form 10-Q for the first quarter of fiscal 2025, to be filed on or around the date hereof.

Dolby is providing the following estimates for its second quarter of fiscal 2025:

 

   

Total revenue is estimated to range from $355 million to $385 million.

 

   

Licensing revenue is estimated to range from $330 million to $360 million.

 

   

Gross margins are anticipated to be approximately 89% on a GAAP basis and approximately 91% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.

 

   

Effective tax rate is anticipated to be around 20.5% on a GAAP basis and around 18.5% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $0.77 to $0.92 on a GAAP basis and from $1.19 to $1.34 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2025:

 

   

Total revenue is expected to range from $1.33 billion to $1.39 billion.

 

   

Licensing revenue is estimated to range from $1.22 billion to $1.28 billion.

 

   

Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $915 million to $925 million on a GAAP basis and from $765 million to $775 million on a non-GAAP basis.

 

   

Dolby expects operating margins to be roughly 20% on a GAAP basis and to be roughly 33% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $2.39 to $2.54 on a GAAP basis and from $3.99 to $4.14 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss first quarter fiscal 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, January 29, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-800-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Wednesday, January 29, 2025, until 8:59 p.m. PT (11:59 p.m. ET) on Wednesday, February 5, 2025 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance. We believe


these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.


Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the second quarter of fiscal 2025 and full year fiscal 2025, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified under the section captioned “Risk Factors” in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)

 

     Fiscal Quarter Ended  
     December 27,
2024
    December 29,
2023
 

Revenue:

    

Licensing

   $ 330,479     $ 293,767  

Products and services

     26,520       21,807  
  

 

 

   

 

 

 

Total revenue

     356,999       315,574  
  

 

 

   

 

 

 

Cost of revenue:

    

Cost of licensing

     21,110       15,736  

Cost of products and services

     19,664       16,324  
  

 

 

   

 

 

 

Total cost of revenue

     40,774       32,060  
  

 

 

   

 

 

 

Gross profit

     316,225       283,514  
  

 

 

   

 

 

 

Operating expenses:

    

Research and development

     66,638       67,033  

Sales and marketing

     94,399       79,003  

General and administrative

     70,092       65,166  

Restructuring charges

     5,216       6,091  
  

 

 

   

 

 

 

Total operating expenses

     236,345       217,293  
  

 

 

   

 

 

 

Operating income

     79,880       66,221  
  

 

 

   

 

 

 

Other income/(expense):

    

Interest income/(expense), net

     2,646       9,187  

Other income, net

     3,525       5,425  
  

 

 

   

 

 

 

Total other income

     6,171       14,612  
  

 

 

   

 

 

 

Income before income taxes

     86,051       80,833  

Provision for income taxes

     (17,981     (13,252
  

 

 

   

 

 

 

Net income including noncontrolling interest

     68,070       67,581  

Less: net income attributable to noncontrolling interest

     (248     (600
  

 

 

   

 

 

 

Net income attributable to Dolby Laboratories, Inc.

   $ 67,822     $ 66,981  
  

 

 

   

 

 

 

Net income per share:

    

Basic

   $ 0.71     $ 0.70  

Diluted

   $ 0.70     $ 0.69  

Weighted-average shares outstanding:

    

Basic

     95,615       95,376  

Diluted

     97,147       97,439  


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)

 

     December 27,
2024
    September 27,
2024
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 520,821     $ 482,047  

Restricted cash

     90,836       95,705  

Accounts receivable, net

     339,304       315,465  

Contract assets, net

     220,892       197,478  

Inventories, net

     31,833       33,728  

Prepaid expenses and other current assets

     82,113       69,994  
  

 

 

   

 

 

 

Total current assets

     1,285,799       1,194,417  

Long-term investments

     86,304       89,267  

Property, plant, and equipment, net

     476,113       479,109  

Operating lease right-of-use assets

     36,972       39,046  

Goodwill and intangible assets, net

     941,661       967,722  

Deferred taxes

     227,021       219,758  

Other non-current assets

     104,732       120,609  
  

 

 

   

 

 

 

Total assets

   $ 3,158,602     $ 3,109,928  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 11,550     $ 17,380  

Accrued liabilities

     360,915       347,529  

Income taxes payable

     20,875       9,045  

Contract liabilities

     37,111       31,644  

Operating lease liabilities

     11,426       12,238  
  

 

 

   

 

 

 

Total current liabilities

     441,877       417,836  

Non-current contract liabilities

     32,481       34,593  

Non-current operating lease liabilities

     33,019       34,754  

Other non-current liabilities

     134,197       135,852  
  

 

 

   

 

 

 

Total liabilities

     641,574       623,035  

Stockholders’ equity:

    

Class A common stock

     55       53  

Class B common stock

     40       41  

Retained earnings

     2,543,413       2,496,255  

Accumulated other comprehensive loss

     (35,542     (19,187
  

 

 

   

 

 

 

Total stockholders’ equity – Dolby Laboratories, Inc.

     2,507,966       2,477,162  

Noncontrolling interest

     9,062       9,731  
  

 

 

   

 

 

 

Total stockholders’ equity

     2,517,028       2,486,893  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 3,158,602     $ 3,109,928  
  

 

 

   

 

 

 


DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

 

     Fiscal Quarter Ended  
     December 27,
2024
    December 29,
2023
 

Operating activities:

    

Net income including noncontrolling interest

   $ 68,070     $ 67,581  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     22,362       17,872  

Stock-based compensation

     36,070       31,894  

Amortization of operating lease right-of-use assets

     2,835       3,088  

Amortization of premium on investments

     —        (895

Provision for/(benefit from) credit losses

     730       (2,101

Deferred income taxes

     (7,307     (5,397

Other non-cash items affecting net income

     (3,059     (1,745

Changes in operating assets and liabilities:

    

Accounts receivable, net

     (24,647     (28,935

Contract assets, net

     (23,416     (35,400

Inventories

     1,340       (9,297

Operating lease right-of-use assets

     (2,487     570  

Prepaid expenses and other assets

     16,867       5,866  

Accounts payable and accrued liabilities

     4,804       (31,993

Income taxes, net

     15,305       6,184  

Contract liabilities

     3,691       (1,116

Operating lease liabilities

     (798     (4,264

Other non-current liabilities

     (3,581     (3,503
  

 

 

   

 

 

 

Net cash provided by operating activities

     106,779       8,409  
  

 

 

   

 

 

 

Investing activities:

    

Purchases of marketable securities

     —        (35,753

Proceeds from sales of marketable securities

     —        1,226  

Proceeds from maturities of marketable securities

     —        41,259  

Purchases of property, plant, and equipment

     (6,779     (6,099

Business combinations, net of cash and restricted cash acquired, and other related payments

     (1,362     —   
  

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

     (8,141     633  
  

 

 

   

 

 

 

Financing activities:

    

Proceeds from issuance of common stock

     22,157       18,301  

Repurchase of common stock

     (15,000     (80,002

Payment of cash dividend

     (31,548     (28,552

Distributions to noncontrolling interest

     (740     (1,047

Shares repurchased for tax withholdings on vesting of restricted stock

     (32,440     (34,562

Equity issued in connection with business combination

     —        722  
  

 

 

   

 

 

 

Net cash used in financing activities

     (57,571     (125,140
  

 

 

   

 

 

 

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

     (7,162     6,790  
  

 

 

   

 

 

 

Net increase/(decrease) in cash, cash equivalents, and restricted cash

     33,905       (109,308

Cash, cash equivalents, and restricted cash at beginning of period

     577,752       817,966  
  

 

 

   

 

 

 

Cash, cash equivalents, and restricted cash at end of period

   $ 611,657     $ 708,658  
  

 

 

   

 

 

 


Licensing Revenue by Market

(unaudited)

The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):

 

     Fiscal Quarter Ended  
Market    December 27,
2024
    December 29,
2023
 

Broadcast

   $ 115,762        35   $ 112,416        38

Mobile

     61,524        19     35,287        12

CE

     49,457        15     53,220        18

PC

     31,256        9     29,679        10

Other

     72,480        22     63,165        22
  

 

 

    

 

 

   

 

 

    

 

 

 

Total licensing revenue

   $ 330,479        100   $ 293,767        100
  

 

 

    

 

 

   

 

 

    

 

 

 

GAAP to Non-GAAP Reconciliations

(unaudited)

The following tables present Dolby’s GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the first quarters of fiscal 2025 and fiscal 2024:

 

Net income:    Fiscal Quarter Ended  
(in thousands)    December 27,
2024
    December 29,
2023
 

GAAP net income attributable to Dolby Laboratories, Inc.

   $ 67,822     $ 66,981  

Stock-based compensation (1)

     36,070       31,894  

Amortization of acquisition-related intangibles (2)

     10,647       3,124  

Restructuring charges

     5,216       6,091  

Income tax adjustments

     (8,886     (9,450
  

 

 

   

 

 

 

Non-GAAP net income attributable to Dolby Laboratories, Inc.

   $ 110,869     $ 98,640  
  

 

 

   

 

 

 

(1) Stock-based compensation included in above line items:

    

Cost of products and services

   $ 487     $ 410  

Research and development

     10,984       10,106  

Sales and marketing

     12,645       10,481  

General and administrative

     11,954       10,897  

(2) Amortization of acquisition-related intangibles included in above line items:

    

Cost of licensing

   $ 6,704     $ 62  

Cost of products and services

     834       534  

Sales and marketing

     754       656  

General and administrative

     1,872       1,872  

Other income, net

     483       —   

 

Diluted earnings per share:    Fiscal Quarter Ended  
     December 27,
2024
    December 29,
2023
 

GAAP diluted earnings per share

   $ 0.70     $ 0.69  

Stock-based compensation

     0.37       0.33  

Amortization of acquisition-related intangibles

     0.11       0.03  

Restructuring charges

     0.05       0.06  

Income tax adjustments

     (0.09     (0.10
  

 

 

   

 

 

 

Non-GAAP diluted earnings per share

   $ 1.14     $ 1.01  
  

 

 

   

 

 

 

Weighted-average shares outstanding - diluted (in thousands)

     97,147       97,439  


The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the second quarter of fiscal 2025 and full year fiscal 2025 included in this release:

 

Gross margin:    Q2 2025     Fiscal 2025  

GAAP gross margin

     89.0     87.0

Stock-based compensation

     0.1     0.1

Amortization of acquisition-related intangibles

     1.9     2.9
  

 

 

   

 

 

 

Non-GAAP gross margin

     91.0     90.0
  

 

 

   

 

 

 
Operating expenses (in millions):    Q2 2025     Fiscal 2025  

GAAP operating expenses (low - high end of range)

   $ 230 - $240     $ 915 - $925  

Stock-based compensation

     (34     (131

Amortization of acquisition-related intangibles

     (3     (9

Restructuring charges

     (3     (10
  

 

 

   

 

 

 

Non-GAAP operating expenses (low - high end of range)

   $ 190 - $200     $ 765 - $775  
  

 

 

   

 

 

 

 

Operating margin:    Fiscal 2025  

GAAP operating margin

     20% +/-  

Stock-based compensation

     10%  

Amortization of acquisition-related intangibles

     3%  
  

 

 

 

Non-GAAP operating margin

     33% +/-  
  

 

 

 
Effective tax rate:    Q2 2025  

GAAP effective tax rate

     20.5%  

Stock-based compensation (low - high end of range)

     (2%) - 0%  

Amortization of acquisition-related intangibles (low - high end of range)

     (1%) - 0%  
  

 

 

 

Non-GAAP effective tax rate

     18.5%  
  

 

 

 

 

Diluted earnings per share:    Q2 2025     Fiscal 2025  
     Low     High     Low     High  

GAAP diluted earnings per share (low - high end of range)

   $ 0.77     $ 0.92     $ 2.39     $ 2.54  

Stock-based compensation

     0.34       0.34       1.36       1.36  

Amortization of acquisition-related intangibles

     0.12       0.12       0.42       0.42  

Restructuring charges

     0.03       0.03       0.10       0.10  

Income tax adjustments

     (0.07     (0.07     (0.28     (0.28
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP diluted earnings per share (low - high end of range)

   $ 1.19     $ 1.34     $ 3.99     $ 4.14  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares outstanding - diluted (in thousands)

     97,400       97,400       97,500       97,500  

Investor Contact:

Peter Goldmacher

415-254-7415

peter.goldmacher@dolby.com

Media Contact:

media@dolby.com

v3.24.4
Document and Entity Information
Jan. 29, 2025
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001308547
Document Type 8-K
Document Period End Date Jan. 29, 2025
Entity Registrant Name DOLBY LABORATORIES, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-32431
Entity Tax Identification Number 90-0199783
Entity Address, Address Line One 1275 Market Street
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94103-1410
City Area Code (415)
Local Phone Number 558-0200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A common stock, $0.001 par value
Trading Symbol DLB
Security Exchange Name NYSE
Entity Emerging Growth Company false

Dolby Laboratories (NYSE:DLB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Dolby Laboratories.
Dolby Laboratories (NYSE:DLB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Dolby Laboratories.